Collection |
Collections
Filters
-
Collection Type
-
-
Special |
CAR-T
-
Special |
Spinraza And Advanced Therapies: A Stakeholder Special
The Spinraza and Advanced Therapies: a stakeholder special issue of Gene Therapy covers a variety of perspectives and includes comments and review papers from SMA research funders, people affected, experts in the advanced therapies field, SMA scientists and clinicians, regulators, ethics and pricing/IP experts, and community stakeholders.
-
Special |
Nanotechnology
-
Focus |
Vector Technology
The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved considerably. There is now a wealth of clinical experience with numerous vector types that have been applied primarily to treatment of cancer and rare metabolic diseases. Viral vectors will likely achieve considerable prominence in the delivery of gene editing tools, providing an important aspect of gene therapy strategies going forward. Still more advanced platforms and vehicle delivery systems are required to enable appropriate level and duration of gene expression in targeted cell types. Recent research into the field of vector technologies are highlighted in publications in the journal Gene Therapy.
-
Special |
Cardiovascular Gene Therapy
-
Special |
Gene Therapy for Eye Diseases
Special Issue led by Guest Editor Robin Ali, University College London, United Kingdom
-
Special |
3rd European Conference and Practical Course on Advanced Gene Vector Technologies: Training on Pharmaceutical Development of Gene Therapy Products
This conference and practical course, held at the 'Université d' Evry – Val d'Essonne', was the 3rd of a series of training initiatives on gene therapy (GT) on behalf of a training project called Vecteurotrain.
-
Special |
2nd European Conference and Practical Course on Pre-clinical Gene Transfer to Train Researchers on Gene Therapy
This special issue contains review articles contributed by speakers of the Second European Conference & Practical Course: Towards clinical Gene Therapy: preclinical gene transfer assessment, held at the Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB) in Bellaterra (Spain) on February 1–14, 2004.
-
Supplement |
Harold W. Siebens Conference
-
Supplement |
Meeting Abstracts